NCT05546229View on ClinicalTrials.gov

Assessment of Methadone and Buprenorphine in Interstitial Fluid

CompletedOBSERVATIONAL
Enrollment

11

Participants

Timeline

Start Date

September 14, 2022

Primary Completion Date

October 31, 2022

Study Completion Date

October 31, 2022

Conditions
Opioid Use Disorder
Interventions
PROCEDURE

Microneedle based interstitial fluid collection

Interstitial fluid will be collected from the skin using microneedles and suction.

Trial Locations (1)

91945

Synergy San Diego, Lemon Grove

Sponsors

Lead Sponsor

Cari Health Inc.
All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Cari Health Inc.

OTHER

NCT05546229 - Assessment of Methadone and Buprenorphine in Interstitial Fluid | Biotech Hunter | Biotech Hunter